Schedule
Registration
Education
Junior Investigator Events
Exhibit Opportunities
Support Opportunities
Industry Wednesday Symposia
Housing & Travel
About Philadelphia
Press Room
Public Symposia
Future Meetings
Past Meetings
Annual Meeting Home
ISSCR Home
 

 

 

 

 

 

 

 

Detailed Schedule at a Glance
This schedule is preliminary and subject to change.
Download the Second Announcement.

Wednesday, June 11, 2008

7:30 a.m. – 6:00 p.m. Registration Open
7:30 a.m. – 5:30 p.m. Speaker Ready Room Open

8:00 a.m. – Noon

Industry Wednesday Symposia
Click here to review the schedule.

8:00 a.m. – 3:00 p.m.

Exhibitor Setup

11:00 a.m. – 4:00 p.m. Poster Presentations Session I Setup

1:00 p.m. – 3:30 p.m.

Plenary I: Presidential Symposium on Developmental Biology
Supported by Johnson & Johnson
Chair: George Q. Daley

Welcome and State of the Society Address
George Q. Daley, ISSCR President

Keynote Address
Professor Sir John B. Gurdon
Wellcome Trust / Cancer Research UK, Cambridge, UK
NUCLEAR REPROGRAMMING BY EGGS AND OOCYTES

Roger K. Patient
Weatherall Institute of Molecular Medicine, Oxford, UK
HOW TO MAKE A BLOOD STEM CELL

Kenneth S. Zaret
Fox Chase Cancer Center, Philadelphia, PA, USA
DEVELOPMENTAL PRINCIPLES FOR GUIDING STEM CELLS TO LIVER AND PANCREAS FATES

Elizabeth Robertson
Sir William Dunn School of Pathology, University of Oxford, Oxford, UK
ROLES FOR THE TBOX GENE EOMESODERMIN IN REGULATING CELL FATE DECISIONS IN THE EARLY MOUSE EMBRYO

Douglas A. Melton
Dept Molecular & Cellular Biology, Harvard University, Cambridge, MA, USA
DIRECT REPROGRAMMING TO MAKE PANCREATIC β CELLS

3:30 p.m. – 4:00 p.m.

Refreshment Break

4:00 p.m. – 6:00 p.m.

Plenary Session II: Hematopoietic Stem Cell Function
Supported by the Black Family Stem Cell Institute, Mount Sinai School of Medicine
Chair: Sean Morrison

Toshio Suda
The Sakaguchi Laboratory of Developmental
Biology, Keio University School of Medicine, Tokyo, Japan
NICHE REGULATION FOR THE QUIESENCE OF
STEM CELLS

Weissman, Irving L.
Stanford University School of Medicine, Stanford, CA, USA
NORMAL AND NEOPLASTIC STEM CELLS

Hiromitsu Nakauchi
University of Tokyo, Tokyo, Japan
CYTOKINE SIGNALS MODULATED VIA LIPID RAFTS INDUCE HIBERNATION IN HEMATOPOIETIC STEM CELLS

Connie Eaves
Terry Fox Laboratory, BC Cancer Agency, Vancouver, BC, Canada
HEMATOPOIETIC STEM CELL REGULATION: A COMBINATION OF CHANGES IN BOTH INTRINSIC AND EXTRINSIC PARAMETERS

5:00 p.m. – 7:30 p.m. Exhibits/Posters Open

5:00 p.m. – 7:30 p.m.

Internet Café Open

6:00 p.m. – 7:30 p.m.

Poster Presentations – Session I, Day I/Opening Reception in Exhibit Hall
Supported by McGowan Institute for Regenerative Medicine / University of Pittsburgh and UPMC Health System

8:00 p.m. – 9:30 p.m.

Junior Investigator Social Hour with Career Panel Discussion

Thursday, June 12, 2008

7:30 a.m. – 6:00 p.m. Registration Open
7:30 a.m. – 5:00 p.m. Speaker Ready Room Open

8:00 a.m. – 9:00 a.m.

Meet the Experts Breakfast
(for preregistered attendees)

9:00 a.m. – 11:15 a.m.

Plenary Session III: Clinical Translation
Supported by McGowan Institute for Regenerative Medicine / University of Pittsburgh and UPMC Health System
Chair: Claudio Bordignon

Nobuko Uchida
StemCells Inc., Palo Alto, CA, USA
TRANSLATING HUMAN CNS STEM CELLS TO CLINIC: NEUROPROTECTION

Craig T. Jordan
University of Rochester, Rochester, NY, USA
CHARACTERIZATION AND TARGETING OF LEUKEMIA STEM CELLS

Olle Lindvall
Co-Chair of the ISSCR Task Force on Clinical Translation of Stem Cells
REPORT OF THE TASK FORCE ON CLINICAL TRANSLATION OF STEM CELLS

Olle Lindvall
University of Lund, Lund, Sweden
STEM CELL-DERIVED DOPAMINE NEURONS FOR CELL REPLACEMENT THERAPY IN PARKINSON’S DISEASE: HOW FAR HAVE WE REACHED?

Katherine A. High
The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Howard Hughes Medical Institute, Philadelphia, PA, USA
LESSONS IN CLINICAL TRANSLATION FROM AAV-MEDIATED GENE THERAPY

11:00 a.m. – 7:00 p.m.

Exhibits/Posters Open

11:00 a.m. – 7:00 p.m. Internet Café Open

11:15 a.m. – 1:00 p.m.

Lunch on your own

11:30 a.m. – Noon

Commercial Tutorials

BD Biosciences                                                   
BD’S DISCOVERY PLATFORMSERVICE: STEM CELL CULTURE ENVIRONMENT DEVELOPMENT AND CELL CHARACTERIZATION FOR CELL BASED ASSAYS AND CELL THERAPY

R&D Systems, Inc.                                             
REAGENTS AND KITS FOR STEM CELL EXPANSION AND IDENTIFICATION: MSC AND ES CELLS

Biolog                                                                   
BIOLOG PHENOTYPE MICROARRAYS FOR MAMMALIAN CELLS

BTX/Harvard Apparatus                                   
BTX ELECTROPORATION FOR EFFICIENT GENE DELIVERY INTO HARD-TO-TRANSFECT CELLS AND IN VIVO APPLICATIONS

Union Biometrica, Inc.
FLOW CYTOMETRY FOR LARGE CELLS AND CELL CLUSTERS

12:15 p.m. – 12:45 p.m.

Commercial Tutorials

BD Biosciences                                                   
CELL SORTING AND IMAGE ANALYSIS OF NEURAL STEM CELLS AND NEURONS DERIVED FROM HUMAN EMBRYONIC STEM CELLS

Visualsonics                                                        
EMBRYONIC DEVELOPMENT: WHAT AND HOW TO IMAGE THE DEVELOPMENT OF AN EMBRYO AND HOW TO PERFORM INTERVENTIONAL PROCEDURES

Invitrogen                                                            
NOVEL CELL CULTURE SYSTEMS FOR STEM CELLS

Stemgent                                                              
STEMGENT: AN INTEGRATED APPROACH TO STEM CELL REAGENTS AND TOOLS

1:00 p.m. – 2:45 p.m.

Concurrent Session I:  
Supported by StemCells, Inc.

Session I A: Somatic Stem Cells                            
Co-Chairs: Amy Wagers & Fiona M. Watt
Amy Wagers
Joslin Diabetes Center, Harvard University and Harvard Stem Cell Institute, Boston, MA, USA
REGENERATIVE POTENTIAL OF SKELETAL MUSCLE STEM CELLS

Jeff Biernaskie
Hospital for Sick Children, Toronto, ON, Canada
SKIN-DERIVED PRECURSORS ARE ADULT STEM CELLS THAT RECONSTITUTE THE DERMIS AND INDUCE HAIR MORPHOGENESIS

Kateri A. Moore
Mount Sinai School of Medicine, New York, NY, USA
QUIESCENT HEMATOPOIETIC STEM CELLS IN BONE MARROW

Fiona M. Watt
Cambridge University, Cambridge, UK
DEFINING THE EPIDERMAL STEM CELL NICHE

Session I B: Stem Cell Microenvironments         
Co-Chairs: Tsvee Lapidot & Linheng Li

Linheng Li
Stowers Institute for Medical Research, Kansas City, MO, USA
STEM CELL NICHE, SIGNALING AND EXPANSION

Olaia Naveiras
Children's Hospital & Harvard Medical School, Boston, MA, USA
BONE MARROW ADIPOCYTES AS NEGATIVE REGULATORS OF THE HEMATOPOIETIC STEM CELL NICHE

Maksim Plikus
University of Southern California, Los Angeles, CA, USA
MACRO-ENVIRONMENTAL REGULATION OF STEM CELL ACTIVITY DURING HAIR FOLLICLE REGENERATION

Tsvee Lapidot
Weizmann Institute of Science, Rehovot, Israel
DYNAMIC INTERACTIONS BETWEEN THE NERVOUS AND IMMUNE SYSTEMS WITH THE MICROENVIRONMENT REGULATE HEMATOPOIETIC STEM CELL MIGRATION, RETENTION AND DEVELOPMENT

Session I C: Novel Emerging Technologies          
Co-Chairs: Ron Weiss & Anthony Whetton

Ron Weiss
Dept of Electrical Engineering, Princeton University, Princeton, NJ, USA
PROGRAMMABLE STEM CELLS: ADVANCED CONTROL THROUGH SYNTHETIC BIOLOGY

Genta Narazaki
Insititute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan
CARDIOVASCULAR CELL DIFFERENTIATION SYSTEM USING MOUSE INDUCED PLURIPOTENT STEM CELLS

Bhaskar Thyagarajan
Invitrogen Corporation, Carlsbad, CA, USA
TARGETING SPECIFIC LOCI IN HUMAN EMBRYONIC STEM CELLS USING SITE-SPECIFIC INTEGRATION

Anthony Whetton
University of Manchester, Manchester, UK
THE APPLICATION OF DISCOVERY PROTEOMICS TO STEM CELL BIOLOGY

Session I D: Roadmap to the Clinic: Ethical & Policy Challenges   
Chair: Insoo Hyun

Jeremy Sugarman
Berman Institute of Bioethics and Department of Medicine
Johns Hopkins University, Baltimore, MD, USA
ETHICS AND TRANSLATIONAL RESEARCH INVOLVING STEM CELL-BASED INTERVENTIONS

Alok Srivastava
Christian Medical College, Vellore, India
ADULT STEM CELL THERAPIES - ETHICAL AND POLICY ISSUES

Angela McNab
Department of Health, London, UK
A LEAP OF FAITH OR A STEP TOO FAR

Timothy Caulfield
Health Law Institute, University of Alberta, Edmonton, AB, Canada
HOPE, HYPE AND QUACKERY? A STUDY OF THE CURRENT MARKET FOR STEM CELL THERAPIES

2:45 p.m. – 3:15 p.m.

Refreshment Break in the Exhibit and Poster Hall

3:15 p.m. – 5:30 p.m.

Plenary Session IV: Cancer Stem Cells
Supported by The California Institute for Regenerative Medicine (CIRM)
Chair: Michael Clarke

Nancy Witty
ISSCR Executive Director’s Report

Judi Lieberman
Immune Disease Institute, Harvard Medical School, Boston, MA, USA
LET-7: A MASTER REGULATOR OF SELF-RENEWAL AND TUMORIGENICITY OF BREAST CANCER INITIATING CELLS

Carla Kim
Children's Hospital Boston, Harvard Medical School and the Harvard Stem Cell Institute, Boston, MA, USA
REGULATION OF BRONCHIOALVEOLAR STEM CELLS AND THEIR ROLE IN LUNG CANCER

Richard M. White
Dana Farber Cancer Institute/Children's Hospital Boston, Boston, MA, USA
AN EXPANDED POOL OF EMBRYONIC NEURAL CREST PROGENITORS PREDISPOSES TO MELANOMA

Richard Gilbertson
St. Jude Children's Research Hospital, Memphis, TN, USA
CANCER STEM CELLS AND THE PERIVASCULAR NICHE: THERE GOES THE NEIGHBORHOOD

Owen N. Witte
University of California, Los Angeles, Howard Hughes Medical Institute, Los Angeles, CA, USA
PROSTATE STEM CELLS AND CANCER PROGRESSION

5:30 p.m. – 7:00 p.m.

Poster Presentations – Session I, Day II/Exhibit Reception

7:00 p.m.

Posters Dismantle

Friday, June 13, 2008

7:00 a.m. – 9:00 a.m. Poster Session II Setup
7:30 a.m. – 6:00 p.m. Registration Open
7:30 a.m. – 5:00 p.m. Speaker Ready Room Open

8:00 a.m. – 9:00 a.m.

Meet the Experts Breakfast
(for preregistered attendees)

9:00 a.m. – 11:15 a.m.

Plenary Session V: Adult Stem Cell Physiology
Supported by the McEwen Centre for Regenerative Medicine
Chair: Ronald McKay

ISSCR Executive Committee
ISSCR New Business Q & A

Peter Lansdorp
Terry Fox Laboratory, BC Cancer Agency and University of British Columbia, Vancouver, BC, Canada
DOES DNA REPLICATION RESULT IN FUNCTIONAL DIFFERENCES BETWEEN SISTER CHROMATIDS?

Mayumi Ito
University of Pennsylvania, Philadelphia, PA, USA
WNT MODULATES THE DIFFERENTIATION STATUS OF INTERFOLLICULAR EPIDERMAL MELANOCYTES ARISING FROM MELANOCYTE STEM CELLS IN THE HAIR FOLLICLE BULGE AFTER WOUNDING OR UVB IRRADIATION

Douglas Lauffenburger
Dept of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA
A QUANTITATIVE SYSTEMS APPROACH TO UNDERSTANDING HOW SIGNALING NETWORKS GOVERN CELL BEHAVIOR

Sally Temple
New York Neural Stem Cell Institute, Rensselaer, NY, USA
A NOVEL PLASTIC STEM CELL FROM THE HUMAN EYE

Sean J. Morrison
University of Michigan/HHMI
THE DECLINE IN STEM CELL SELF-RENEWAL DURING AGING

11:00 a.m. – 6:30 p.m.

Exhibits/Posters Open

11:00 a.m. – 6:30 p.m.

Internet Café Open

11:15 a.m. – 1:00 p.m.

Lunch

11:30 a.m. – Noon

Commercial Tutorials

BD Biosciences                                                   
ENABLING STEM CELL DISCOVERY THROUGH HIGH-CONTENT IMAGING

Nikon Instruments Inc.                                      
NEW IMAGING DEVICES FOR OBSERVING AND MEASURING STEM CELL DIFFERENTIATION AND VIABILITY

Millipore                                                               
PROGENITOR CELL TARGETING ENABLES IMPROVED 2D AND 3D CULTURE OF EPITHELIAL CELLS

Stemgent                                                              
STEMGENT: MEDIA FOR STEM CELLS

The Automation Partnership
NEW AUTOMATED TOOLS AND EQUIPMENT FOR STEM CELL CULTURE AND SCALE-UP

12:15 p.m. – 12:45 p.m.

Commercial Tutorials

Invitrogen                                                            
MicroRNA IN hESC DIFFERENTIATION

R&D Systems, Inc.                                             
ExactaChIP™ CHROMATIN IMMUNOPRECIPITION AND PlusCellect™ POSITIVE CELL SELECTION KITS FOR STEM CELL RESEARCH

Millipore                                                               
HASSLE-FREE USE OF hES CELL-DERIVED NEURAL CELLS: ENStem-A™

Corning Incorporated                                         
AN ECM-MIMETIC TOPOGRAPHICAL SURFACE IMPROVES GROWTH AND DIFFERENTIATION OF MESENCHYMAL STEM CELLS

1:00 p.m. – 2:45 p.m.

Concurrent Session II:

Session II A: Metabolism of Stem Cells
Co-Chairs: Mark Noble & M. Celeste Simon

M. Celeste Simon
HHMI, Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
OXYGEN AVAILABILITY, EMBRYONIC DEVELOPMENT AND STEM CELL FUNCTION

Celine Filippi
Scottish Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK
MITOCHONDRIAL FUNCTION DURING THE DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS INTO HEPATOCYTE-LIKE CELLS

Eran Meshorer
The Hebrew University of Jerusalem Institute of Life Sciences, Jerusalem, Israel
GLOBAL TRANSCRIPTIONAL ACTIVITY IN PLURIPOTENT EMBRYONIC STEM CELLS

Mark Noble
University of Rochester Medical Center, Rochester, NY, USA
INTRACELLULAR REDOX STATUS AS A CENTRAL INTEGRATOR OR PROGENITOR CELL FUNCTION IN DEVELOPMENT AND PATHOLOGY: NOVEL MECHANISMS AND NEW INSIGHTS

Session II B: Quantitative Approaches to Stem Cell Biology
Co-Chairs: Berthold Gottgens & Ihor Lemischka

Berthold Gottgens
Cambridge University, Cambridge, UK
GENOMIC REGULATORY NETWORK MODELS FOR DEVELOPING BLOOD STEM CELLS

Alice Gerrits
University Medical Center Groningen, Groningen, The Netherlands
A MULTI-DIMENSIONAL GENETICAL GENOMICS APPROACH TO STUDY CELL FATE DECISIONS DURING HEMATOPOIETIC DEVELOPMENT

Jeroen Krijgsveld
Utrecht University, Utrecht, The Netherlands
QUANTITATIVE PHOSPHO-PROTEOMICS OF HUMAN EMBRYONIC STEM CELL DIFFERENTIATION

Ihor R. Lemischka
Black Family Stem Cell Institute, Mount Sinai School of Medicine, New York, NY, USA
DISSECTION OF CELL FATE DECISION PROCESSES IN EMBRYONIC STEM CELLS

Session II C: Aging of Stem Cells
Chair: Thomas A. Rando
Co-Chair: Wei Tong

Thomas A. Rando
Stanford University, Palo Alto, CA, USA
REGULATION OF STEM CELL FUNCTION IN ADULT AND AGED TISSUES

Hugo A. Alves
University Twente, Enschede, The Netherlands
ACCUMULATION OF DNA DAMAGE AND ACTIVATION OF THE DNA DAMAGE RESPONSE PATHWAY IS ASSOCIATED WITH LOSS OF MULTIPOTENCY UPON CULTURE EXPANSION OF HUMAN MESENCHYMAL STEM CELLS

Eric J. Brown
Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
PREMATURE AGING AND TISSUE REGENERATIVE FAILURES IN ATRmKO MICE ARE ACCELERATED BY THE ABSENCE OF p53

Derrick J. Rossi
Harvard Stem Cell Institute, Boston, MA, USA
DNA DAMAGE ATTENUATES THE FUNCTIONAL CAPACITY OF HEMATOPOIETIC STEM CELLS DURING AGING

Wen-Shu Wu
MMC Research Institute, Scarborough, ME, USA
DELETION OF TRANSCRIPTIONAL REPRESSOR SLUG LEADS TO AGE-RELATED PHENOTYPES AND STEM CELL DEFECT

Session II D: Clinical Translation & Disease Models
Chair: Markus Grompe
Co-Chair: Giulio Cossu

Markus Grompe
Papé Family Pediatric Institute, Oregon Stem Cell Center, Oregon Health & Science University, Portland, OR, USA
CHALLENGES TO CLINICAL CELL-BASED LIVER THERAPY

Darko Bosnakovski
University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA
FSHD: A MUSCULAR DYSTROPHY WITH A STEM CELL ETIOLOGY

Giulio Cossu
San Raffaele Scientific Institute, Milan, Italy
MESOANGIOBLASTS: FROM MUSCLE DEVELOPMENT TO CELL THERAPY FOR MUSCULAR DYSTROPHY

Hideaki Kagami
The University of Tokyo, The Institute of Medical Science, Tokyo, Japan
A CLINICAL STUDY ON ALVEOLAR BONE REGENERATION USING AUTOLOGOUS BONE MARROW STROMAL CELLS

Francesca Pellicano
University of Glasgow, Glasgow, UK
BMS-214662 INDUCES APOPTOSIS IN QUIESCENT PRIMARY CML STEM CELLS TROUGH DISRUPTION OF THE PLASMA MEMBRANE AND ACTIVATION OF CASPASE 3

2:45 p.m. – 3:15 p.m.

Refreshment Break

3:15 p.m. – 5:00 p.m.

Concurrent Session III:

Session III A: Cancer Stem Cell Biology
Chair: Dominique Bonnet
Co-Chair: Kristen M. Smith

Dominique Bonnet
Cancer Research UK, London Research Institute, London, UK
LEUKEMIC STEM CELLS: HOW TO TARGET THEM?

Kazuhito Naka
Kanazawa University, Kanazawa, Japan
PROSPECTIVE IDENTIFICATION OF LEUKEMIC STEM CELLS BY PROMOTER ACTIVITY OF NUCLEOSTEMIN GENE

Kristen M. Smith
The Hospital for Sick Children, Toronto, ON, Canada
TARGETING NEUROBLASTOMA TUMOR-INITIATING CELLS: HIGH-THROUGHPUT SCREENING STRATEGIES TO IDENTIFY NOVEL CHEMOTHERAPEUTICS

Junping Wei
Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
MICROENVIRONMENT DETERMINES LINEAGE FATE OF LEUKEMIA STEM CELLS IN MIXED LINEAGE LEUKEMIA

John Yu
Cedars-Sinai Medical Center, Los Angeles, CA, USA
HEDGEHOG SIGNALING REGULATES BRAIN TUMOR STEM CELL SELF-RENEWAL AND PORTENDS A SHORTER SURVIVAL FOR PATIENTS WITH PTEN-COEXPRESSING GLIOBLASTOMAS

Session III B: MicroRNAs & Cell Fate Determination
Chair: Eran Hornstein
Co-Chair: Haifan Lin

Eran Hornstein
Weizmann Institute of Science, Rehovot, Israel
miRNA REGULATE PANCREAS DEVELOPMENT AND FUNCTION

Christopher P. Arnold
Stanford University School of Medicine, Stanford, CA, USA
MOUSE ADULT STEM CELL MICRORNAS AND THEIR FUNCTIONS IN SELF-RENEWAL

Richard I. Gregory
Children's Hospital Boston, Boston, MA, USA
LIN-28 SELECTIVELY BLOCKS MICRORNA PROCESSING IN MOUSE EMBRYONIC STEM CELLS

Xuekun Li
University of New Mexico, Albuquerque, NM, USA
MECP2-MEDIATED EPIGENETIC REGULATION OF A MICRORNA HAS SIGNIFICANT REGULATORY ROLE IN MOUSE NEURAL STEM CELL PROLIFERATION AND DIFFERENTIATION

Monica Teta
University of Pennsylvania School of Medicine, Philadelphia, PA, USA
THE miRNA PROCESSING ENZYME DICER IS REQUIRED FOR MAINTENANCE OF HAIR FOLLICLE STEM CELLS

Session III C: Cell Cycle Regulation & Signaling
Co-Chairs: Kathryn Anderson & Charles J. Sherr

Charles J. Sherr
HHMI, St. Jude Children's Research Hospital, Memphis, TN, USA
Ink4A-Arf TUMOR SUPPRESSORS LIMIT SELF-RENEWAL

Robert Blelloch
University of California San Francisco, San Francisco, CA, USA
EMBRYONIC STEM CELL SPECIFIC MICRORNAS REGULATE THE G1/S TRANSITION PROMOTING THEIR RAPID PROLIFERATION

Xinjiang Wu
University of Pennsylvania, Philadelphia, PA, USA
WNT/BETA-CATENIN SIGNALING REGULATES EXPANSION BUT NOT SURVIVAL OF MAMMARY STEM CELLS

Kathryn Anderson
Sloan Kettering Institute, New York, NY, USA
CILIA AND DEVELOPMENTAL SIGNALING

Session III D: Visualization of Stem Cells
Chair: Michel C. Nussenzweig
Co-Chair: Fanie Barnabe-Heider

Michel C. Nussenzweig
Rockefeller University, New York, NY, USA
THE NATURAL HISTORY OF DENDRITIC CELLS IN PERIPHERAL LYMPHOID ORGANS OF MICE

Fanie Barnabe-Heider
Karolinska Institute, Stockholm, Sweden
IDENTIFICATION AND CHARACTERIZATION OF STEM/PROGENITOR CELLS UPON SPINAL CORD INJURY

Alessia Capotondo
San Raffaele Telethon Institute for Gene Therapy, Milan, Italy
VISUALIZATION OF HEMATOPOIETIC STEM CELLS HOMING TO THE BRAIN OF MICE AFFECTED BY INHERITED LEUKODYSTROPHIES

Zhu Jianhong
Fudan University Huashan Hospital, Shanghai, China
A PILOT CLINICAL STUDY: TRACKING NEURAL STEM CELLS IN BRAIN TRAUMA PATIENTS

Zongjin Li
Stanford University, Stanford, CA, USA
ENDOTHELIAL PROGENITOR CELLS FROM HUMAN EMBRYONIC STEM CELLS: ISOLATION AND TRANSPLANTATION FOR MYOCARDIAL INFARCTION

6:45 p.m.– 8:00 p.m.

Standards and Methodology of iPS Cells Panel Discussion
Supported by iZumi
Moderator – George Q. Daley

Panel
Alexander Meissner
Harvard University/Broad Institute, Cambridge, MA, USA

Kathrin Plath
UCLA School of Medicine, Los Angeles, CA, USA

Kazuhiro Sakurada
IZumi Inc., San Francisco, CA, USA

Shinya Yamanaka
Kyoto University, Kyoto, Japan

Junying Yu, PhD
University of Wisconsin, Madison, WI, USA

5:00 p.m. – 6:30 p.m.

Poster Presentations – Session II, Day I/Exhibit Reception

9:00 p.m. – 11:00 p.m.

All-Attendee Dessert Mixer

Saturday, June 14, 2008

8:00 a.m. – 5:00 p.m. Registration Open
8:00 a.m. – 4:00 p.m. Speaker Ready Room Open

9:00 a.m. – 11:15 a.m.

Plenary Session VI: Embryonic Stem Cells
Supported by Applied Biosystems
Chair: Alan Trounson

Fiona M. Watt
ISSCR President Elect’s Address

Shin-Ichi Nishikawa
RIKEN Center for Developmental Biology, Kobe, Japan
ES CELL DIFFERENTIATION CULTURE FOR INVESTIGATING LINEAGE COMMITMENT

Gordon M. Keller
McEwen Center for Regenerative Medicine, Ontario Cancer Institute, Toronto, ON, Canada
LINEAGE SPECIFIC DIFFERENTIATION OF EMBRYONIC STEM CELLS

Thomas P. Zwaka
Baylor College of Medicine, Houston, TX, USA
RONIN IS ESSENTIAL FOR EMBRYOGENESIS AND THE PLURIPOTENCY OF MOUSE ES CELLS AND ACTS INDEPENDENTLY OF CANONICAL PATHWAYS

Christine L. Mummery
Hubrecht Laboratory, Utrecht, The Netherlands
CARDIOMYOCYTES FROM HUMAN EMBRYONIC STEM CELLS

Janet Rossant
SickKids Research Institute and the Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada
STEM CELLS FROM THE MAMMALIAN BLASTOCYST- NOT ALL STEM CELLS ARE ALIKE

11:00 a.m. – 7:00 p.m.

Exhibits/Posters Open

11:00 a.m. – 7:00 p.m.

Internet Café Open

11:15 a.m. – 1:00 p.m.

Lunch

11:30 a.m. – Noon

Commercial Tutorials

Applied Biosystems
CHARACTERIZATION OF HUMAN EMBRYONIC STEM CELL LINES BY GENE EXPRESSION ANALYSIS

STEMCELL Technologies Inc.
PRODUCTS TO STANDARDIZE AND SIMPLIFY HUMAN EMBRYONIC AND INDUCED PLURIPOTENT STEM CELL RESEARCH

Millipore
ReNcell VM AND CX HUMAN NEURAL PROGENITORS: A RENEWABLE AND CONSISTENT SUPPLY OF HUMAN FUNCTIONAL NEURONS

Stemgent
STEMGENT: BIOMATERIALS FOR STEM CELLS

12:15 p.m. – 12:45 p.m.

Commercial Tutorials

Applied Biosystems
DISTINCT MicroRNA EXPRESSION SIGNATURES IN HUMAN CANCER STEM CELLS

STEMCELL Technologies Inc.
PRODUCTS TO STANDARDIZE HEMATOPOIETIC AND NON-HEMATOPOIETIC STEM CELL RESEARCH

Invitrogen
CLICK CHEMISTRY, MAKING BIODISCOVERY A SNAP

Cellartis AB
NEW hES CELL-DERIVED PLATFORMS AND TOOLS

1:00 p.m. – 2:45 p.m.

Concurrent Session IV:

Session IV A: Stem Cells in Early Embryogenesis
Chair: Hitoshi Niwa
Co-Chair: Carl L. Schildkraut

Hitoshi Niwa
RIKEN, CDB, Kobe, Japan
TRANSCRIPTION FACTOR NETWORK FOR SELF-RENEWAL AND DIFFERENTIATION OF MOUSE ES CELLS

Mohamedi N. Kagalwala
Salk Institute for Biological Studies, La Jolla, CA, USA
REST/NRSF MAINTAINS SELF-RENEWAL AND PLURIPOTENCY OF EMBRYONIC STEM CELLS

Patrick J. Paddison
Cold Spring Harbor Lab, Cold Spring Harbor, NY, USA
SWI/SNF IS REQUIRED FOR ESC LINEAGE COMMITMENT AND SPECIFICATION

Carl L. Schildkraut
Albert Einstein College of Medicine, Bronx, NY, USA
THE REGULATION OF DNA REPLICATION INITIATION IN MOUSE AND HUMAN EMBRYONIC STEM CELLS

Michele M. Souyri
INSERM U602, Villejuif, France
THE MAJORITY OF ADULT HEMATOPOIETIC CELLS ARE DESCENDENTS OF VE-CADHERIN EXPRESSING ANCESTORS

Session IV B: Stem Cell Fate Choices
Chair: Mitinori Saitou
Co-Chair: Linzhao Cheng

Mitinori Saitou
CDB RIKEN, Kobe, Japan, Kyoto University, Kyoto, Japan
A SIGNALING PRINCIPLE FOR THE SPECIFICATION OF GERM CELL FATE IN MICE

Valerie Gouon-Evans
Mount Sinai School of Medicine, New York, NY, USA
ENDOTHELIAL CELLS SUPPORT SURVIVAL, GROWTH AND HEPATIC SPECIFICATION OF MOUSE ES CELL-DERIVED ENDODERM

Jacob Hanna
Whitehead Institute for Biomedical Research, Cambridge, MA, USA
REPROGRAMMING OF TERMINALLY DIFFERENTIATED MATURE B LYMPHOCYTES TO PLURIPOTENCY WITH DEFINED FACTORS

Benjamin Reubinoff
The Hadassah Human Embryonic Stem Cell Research Center, The Goldyne Savad Institute of Gene Therapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
TRANSPLANTED HESC-DERIVED RETINAL PIGMENT EPITHELIAL CELLS IMPROVE VISUAL FUNCTION IN THE RCS RAT MODEL OF RETINAL DEGENERATION

Cheryle A. Seguin
The Hospital for Sick Children, Toronto, ON, Canada
ESTABLISHMENT OF ENDODERM PROGENITORS FROM HUMAN EMBRYONIC STEM CELLS

Session IV C: Stem Cell Patterning
Chair: Robb Krumlauf
Co-Chair: Andrea Brand

Yechiel Elkabetz
Sloan-Kettering Cancer Center, New York, NY, USA
IDENTIFICATION AND PROSPECTIVE ISOLATION OF A NOVEL, FUNCTIONALLY DISTINCT EARLY NEURAL STEM CELL STAGE DERIVED FROM HUMAN EMBRYONIC STEM CELLS

Yongchao Ma
Children's Hospital Boston/Harvard Medical School, Boston, MA, USA
REGULATION OF SPINAL MOTOR NEURON FATE SPECIFICATION IN NEURAL STEM CELLS

Jonathan M.W. Slack
Stem Cell Institute, University of Minnesota, Minneapolis, MN, USA
TAIL REGENERATION IN XENOPUS TADPOLES

Thomas Touboul
INSERM U804, Kremlin Bicetre, France
DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS INTO HEPATIC PROGENITORS BY REPRODUCING THE MAIN DEVELOPMENTAL STAGES

Robb Krumlauf
Stowers Institute for Medical Research, Kansas City, MO, USA
TITLE TBD

Session IV D: Bio-engineering: Artificial Scaffolds
Chair: Yilin Cao
Co-chair: Helen M. Blau

Sangeeta Bhatia
Massachusetts Institute of Technology, Brigham & Women's Hospital, Cambridge, MA, USA
ENGINEERING THE STEM CELL MICROENVIRONMENT: MICROTECHNOLOGY TOOLS FOR HIGH-THROUGHPUT ANALYSIS

Mohammad F. Chowdhury
University of Toronto, Toronto, ON, Canada
SITE-SPECIFIC PATTERNED DIFFERENTIATION OF MURINE EMBRYONIC STEM CELLS TO VASCULAR CELLS

Helen M. Blau
Stanford University School of Medicine, Stanford, CA, USA
STEM CELL BEHAVIOR IN BIOENGINEERED NICHES

Linda Griffith
Massachusetts Institute of Technology, Cambridge, MA, USA
BIOPHYSICAL CONTROL OF EPIDERMAL GROWTH FACTOR (EGF) PRESENTATION DICTATES BONE MARROW-DERIVED CONNECTIVE TISSUE PROGENITOR RESPONSES TO EGF

2:45 p.m. – 3:15 p.m.

Refreshment Break in the Exhibit

3:15 p.m. – 5:30 p.m.

Closing Plenary VII: Reprogramming and Epigenetics
Supported by The New York Stem Cell Foundation (NYSCF)
Chair: Ian Wilmut

Shinya Yamanaka
Center for iPS cell Research and Application (CiRA), Kyoto University, Kyoto, Japan
INDUCTION OF PLURIPOTENCY BY DEFINED FACTORS

Thomas Graf
ICREA and Center for Genomic Regulation, Barcelona, Spain
TRANSCRIPTION FACTOR INDUCED BLOOD CELL TRANS-DIFFERENTIATION

Bradley Bernstein
Massachusetts General Hospital and Broad Institute, Charlestown, MA, USA
GENOMEWIDE STUDIES OF THE PLURIPOTENT CHROMATIN STATE

Wolf Reik
The Babraham Institute, Cambridge, UK
EPIGENETIC REGULATION OF LINEAGE COMMITMENT AND PLURIPOTENCY IN THE MAMMALIAN EMBRYO

Rudolf Jaenisch – 2008 Anne McLaren Memorial lecture
Whitehead Institute for Biomedical Research, Cambridge, MA, USA
STEM CELLS, SOMATIC CELLS AND NUCLEAR REPROGRAMMING: WHAT IS NEXT?

5:30 p.m. – 7:00 p.m. Poster Presentations – Session II, Day II/ Closing Exhibit Reception

7:00 p.m.

Poster Presentations Session II/Exhibitor Teardown

7:00 p.m.

6th ISSCR Annual Meeting Adjourns

Updated: June 6, 2008

 

 

 



Platinum Support
Gold Support
Silver Support
Bronze Support
General Support